Urocid-N (1500 mg+250 mg)/5 ml (Oral Solution)
200 ml bottle: ৳ 200.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Potassium citrate citric acid |
| Company | One pharma ltd |
Indications
- Relief of discomfort in urinary tract infections
- Prevention of kidney stone
- Prevention of gout with uricosuric agent
- Acidosis caused by kidney diseases
Pharmacological Action
- Systemic alkalizer
- Metabolized to Potassium Bicarbonate
- Alkalinizes urine without causing systemic alkalosis
- Pleasant-tasting oral solution
- Highly palatable and tolerable
Dosage & Administration
- Adult dosage: 10 ml 3 times daily, diluted with 1 glass of water
- Child (1-6 years) dosage: 5 ml 3 times daily, diluted with 1/2 glass of water
- Adult dosage for kidney stones, gout prevention, and kidney disease-induced acidosis: 10-15 ml 4 times daily, diluted with 1 glass of water
- Pediatric dosage for kidney stones, gout prevention, and kidney disease-induced acidosis: 5-10 ml 4 times daily, diluted with 1/2 glass of water
Interaction
Concurrent administration may lead to toxicity
Contraindications
Severe renal impairment, untreated Addison's disease, acute dehydration, severe myocardial damage, hyperkalemia
Side Effects
- Well tolerated in patients with normal renal function and urinary output
- Caution needed in patients with abnormal renal mechanisms to avoid hyperkalemia or alkalosis
- Potassium intoxication symptoms: listlessness, weakness, mental confusion, tingling of extremities
Pregnancy & Lactation
No information available
Precautions & Warnings
- Caution in patients with low urinary output
- Dilution with water to minimize gastrointestinal injury
- Preferably taken after meals
- Large doses may cause hyperkalemia and alkalosis, especially in the presence of renal disease
Overdose Effects
- Rarely causes serious hyperkalemia in persons with normal excretory mechanisms
- Immediate treatment required if hyperkalemia occurs
- Treatment measures: elimination of potassium-containing foods or medications, intravenous administration of dextrose solution, use of exchange resins, hemodialysis, or peritoneal dialysis
Therapeutic Class
- Prevention of repeated kidney stone formation
- Urinary Alkalinizing Agent
Storage Conditions
Keep below 30°C, away from light and moisture, out of the reach of children
Related Brands
- Alken (1500 mg+250 mg)/5 ml (Oral Solution) - al-madina-pharmaceuticals-ltd
- Ural-K (1500 mg+250 mg)/5 ml (Oral Solution) - beximco-pharmaceuticals-ltd
- Kcit (1500 mg+250 mg)/5 ml (Oral Solution) - navana-pharmaceuticals-ltd
- Citrosol (1500 mg+250 mg)/5 ml (Oral Solution) - acme-laboratories-ltd
- CK (1500 mg+250 mg)/5 ml (Oral Solution) - popular-pharmaceuticals-ltd